Over the past year, there have been promising results from multiple early stage clinical trials evaluating cancer vaccines, one type of immunotherapy, in pancreatic cancer patients. From the AMPLIFY-201 trial […]
Targeting immune suppression to treat pancreatic cancer
While immunotherapy, treatment that ignites an anti-tumor immune response, has been transformational for multiple solid tumors such as melanoma and lung cancer, pancreatic ductal adenocarcinoma (PDAC) is largely resistant. Immunotherapy […]
Overcoming immunotherapy resistance in pancreatic cancer
Immunotherapy, a type of treatment aimed at engaging the immune system – namely, T cells – to attack and kill cancer cells, has had success and redefined care in multiple […]
Researchers Aim to Prevent Liver Metastasis in Pancreatic Cancer Patients
Pancreatic cancer is still one of the most lethal cancers, in part, because it has spread or metastasized by the time it is diagnosed. One common site of metastasis for […]
Engineering CAR T cells to overcome immune suppression in pancreatic cancer
Chimeric antigen receptor (CAR) T cells, an immunotherapy that has been successful in treating blood cancers, has had limited efficacy in solid tumors including in pancreatic cancer. Greg Allen, MD, […]
Prepare and Thrive Through Pancreatic Cancer Treatment
Pancreatic cancer treatment is complex and often involves a combination of chemotherapy, surgery, and a demanding recovery. At the Hirshberg Foundation’s 20th Annual Symposium, Barbara Jagels, RN, MHA, CPHQ, Executive […]
